Skip to main content
Figure 1 | Journal of Neuroinflammation

Figure 1

From: Anti-inflammatory recombinant TSG-6 stabilizes the progression of focal retinal degeneration in a murine model

Figure 1

Continuous funduscopic monitoring. (A) Representative funduscopic photographs of a pair of eyes in one mouse monitored for two months. The TSG-6 treated eye (right) showed fewer retinal lesions than the control eye (left) after two months. (B) Pairwise plotting of 23 pairs of eyes showing different progressing scores between the two eyes. Some eye pairs had identical scores and the numbers of overlapped dots are listed by the dots. The triangles indicate stable or worse lesions. The squares indicate improved lesions. (C) The average scores of retinal lesions in treated and untreated eyes showing lower scores in the treated eyes.

Back to article page